‘War over the cancer dollar': Behind the scenes, Mass General Brigham fights Dana-Farber's proposed hospital
Get Starting Point
A guide through the most important stories of the morning, delivered Monday through Friday.
Enter Email
Sign Up
The filings show just how contentious the split between Dana-Farber and Mass General Brigham has become, and hints at more strife to follow as the project moves toward final sign-offs from key state agencies.
Related
:
Advertisement
'In most of the country, it's a war against cancer. Here, it's a war over the cancer dollar,' said Paul Hattis, a senior fellow at the Lown Institute, a Needham-based health care think tank. 'For MGB and Dana-Farber, it's a function of: to fill this 300-bed new building, are those patients going to come from the Brigham, or everywhere else? That's the crux of their difference of opinion.'
Massachusetts' cancer care landscape has been shifting since Dana-Farber announced in September 2023 that it planned to end its arrangement with the Brigham by 2028 and build its own cancer facility in partnership with MGB's rival, Beth Israel Deaconess Medical Center. Over the past year, both
Quietly, the health systems have also been battling over the size, scope, and cost implications of the proposed hospital before state regulators, with the parent organization for the Brigham contesting Dana-Farber's justifications for the new project, and ringing warning bells about the ripple effects if it moves forward.
Advertisement
A sign at Dana-Farber Cancer Institute in November 2023.
Craig F. Walker/Globe Staff
'Because these beds are not needed by [Dana-Farber], the proposed project will destabilize the Commonwealth's health care system,' MGB said in a Feb. 13 letter to state officials. 'If built as proposed, the new hospital will lead to increased healthcare costs, a more expensive labor market, a damaging shift of patients from community hospitals that currently provide cancer care, and a critical worsening of [emergency department] capacity and boarding, which is already at a crisis level.'
Dana-Farber's proposals call for a 688,100-square-foot inpatient hospital on the campus of Beth Israel Deaconess Medical Center, jointly staffed with Beth Israel and largely overseen by Dana-Farber. In all, the proposal seeks to move inpatient cancer care, currently at Brigham and Women's,
to the new hospital.
Throughout its application, Dana-Farber has asserted its current patients — those served directly by Dana-Farber and through its Brigham partnership — will follow Dana-Farber to its new collaboration.
Such a change would not increase health care spending beyond the state's annual 3.6 percent benchmark, Dana-Farber's hired consultants said in a cost analysis in January. Dana-Farber has suggested that care delivered at Dana-Farber and BIDMC would be less expensive than that at the Brigham and at Massachusetts General Hospital, leading to lower medical spending.
Related
:
Mass General Brigham wasted little time pushing back, filing within weeks a nine-page letter with DPH staff calling Dana-Farber's analysis 'flawed, leading to unrealistically low estimates of the potential increase in healthcare costs.' MGB expects only 30 percent of Brigham patients might move to the new Dana-Farber facility.
Advertisement
Rather than drawing patients from Brigham beds, Mass General Brigham said, the new hospital will in fact attract approximately 5,000 patients from other hospitals, including other academic medical centers in Boston and community institutions all over the state, which would result in higher overall costs for cancer care.
Among other criticisms, MGB said the project will drive up labor costs, with the hiring of
what amounts to approximately 2,400 new, full-time positions, putting pressure on an already tight medical job market. In all, the project could increase total medical spending by as much as 14 percent, MGB said.
Ultimately, DPH staff relied on Dana-Farber's cost analysis, and confirmed the project met all necessary requirements. The department did recommend imposing some conditions on the new hospital, such as
metrics that will track how many patients Dana-Farber serves on MassHealth, the state's Medicaid program for low-income people. The DPH staff also suggest tracking revenue from patient care delivered in the hospital to ensure it stays below state limits on health care growth, and to develop a plan, if the amounts are exceeded, for Dana-Farber to invest in initiatives for underserved populations.
Dana-Farber celebrated its step toward approval in a statement.
A bridge, called the Pan-Mass Challenge Bridge to Progress, connects the Dana-Farber Cancer Institute and Brigham and Women's Hospital in Boston. The two partners plan to sever their ties.
Craig F. Walker/Globe Staff
State officials 'undertook a robust and extensive review process that confirms the need for our new inpatient cancer hospital and recognizes its potential cost savings on total medical expenditures in the Commonwealth,' a Dana-Farber spokesperson said in an email.
The hospitals have more than just a vision for patient care on the line. Huge portions of Brigham's revenue are at stake as Dana-Farber walks out the door, and tries to bring patients along with it. Approximately 40 percent of all Brigham surgeries are related to cancer, Brigham spokespeople have previously said. The hospital also conducts 100,000 radiation oncology treatments annually. One in four patients tested at the Brigham's emergency room has cancer, and 8,700 patients are cared for by Brigham cancer experts in the hospital
each year.
Advertisement
In addition to the vote by the Public Health Council scheduled for March, the project must be vetted by the state Health Policy Commission, which is expected to release preliminary results next week. Those findings may also influence the Public Health Council decision.
Some health care groups that are not involved with the project had a lukewarm assessment of the DPH report, in particular decrying what they said was a lack of meaningful conditions to control costs.
'At a time when we need to be focused on health care costs, the staff recommendations seem to be very weak in holding this new entity accountable to the cost benchmark,' said Lora Pellegrini, chief executive of the Massachusetts Association of Health Plans, a trade group representing insurers.
Hattis, of the Lown Institute, was also not convinced the Dana-Farber project would reduce health care spending, and expects a more robust analysis by the state's Health Policy Commission.
'It's not clear to me that the war over the cancer dollar leads to something good for the consumer,' Hattis said. 'The state's job, since the war is here and will be here no matter what, is to make sure that this war falls for the benefit of consumers, and not simply the provider actors in the mix.'
Jessica Bartlett can be reached at
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Epoch Times
2 hours ago
- Epoch Times
Malfunctioning Insulin Pumps Recalled After 59 Injuries
San Diego-based Tandem Diabetes Care, Inc. is voluntarily recalling insulin pumps used to manage blood sugar, the company said in an Aug. 12 announcement by the Food and Drug Administration. Insulin pumps are wearable devices that deliver insulin at predetermined doses at specific times. Such devices can feature alarm functions to alert users about various situations, such as issues with insulin delivery.
Los Angeles Times
4 hours ago
- Los Angeles Times
UnitedHealth Group shares climb as Buffett's Berkshire Hathaway discloses stake in the insurer
Shares of UnitedHealth Group are surging before the market open Friday as Warren Buffett's Berkshire Hathaway disclosed that it recently purchased shares of the beleaguered insurer. Berkshire Hathaway bought around 5 million shares of UnitedHealth last quarter, according to a regulatory filing. The stake was valued at about $1.57 billion. Buffett plans to retire as CEO at the end of the year after six decades of building Berkshire Hathaway. Many investors comb through Berkshire's filings every quarter because they like to follow Buffett's moves. The filing doesn't make clear who at Berkshire handled the investment. Besides Buffett, Ted Weschler and Todd Combs also pick stocks, but they generally handle smaller portfolios and Combs also serves as Geico's CEO. Besides stocks, Berkshire owns dozens of companies in a variety of industries including Geico insurance, BNSF railroad, several major utilities and an assortment of manufacturing and retail companies. The Omaha, Nebraska-based company's holdings include many well-known brands like See's Candy and Dairy Queen. UnitedHealth has been dealing with a series of difficulties. Last month the company said that it was cooperating with federal criminal and civil investigations involving its market-leading Medicare business. The health care giant said at the time that it had contacted the Department of Justice after reviewing media reports about investigations into certain elements of its business. Earlier this year, The Wall Street Journal said federal officials had launched a civil fraud investigation into how the company records diagnoses that lead to extra payments for its Medicare Advantage, or MA, plans. Those are privately run versions of the government's Medicare coverage program mostly for people ages 65 and over. The company's UnitedHealthcare business covers more than 8 million people as the nation's largest provider of Medicare Advantage plans. The business has been under pressure in recent quarters due to rising care use and rate cuts. The Journal said in February, citing anonymous sources, that the probe focused on billing practices in recent months. The paper has since said that a federal criminal health care-fraud unit was investigating how the company used doctors and nurses to gather diagnoses that bolster payments. UnitedHealth Group Inc. runs one of the nation's largest health insurance and pharmacy benefits management businesses. It also operates a growing Optum business that provides care and technology support. UnitedHealth's stock has mostly shed value since December, when UnitedHealthcare CEO Brian Thompson was fatally shot in midtown Manhattan on his way to the company's annual investor meeting. A suspect, Luigi Mangione, has been charged in connection with the shooting. In April, shares plunged some more after the company cut its forecast due to a spike in health care use. A month later, former CEO Andrew Witty resigned, and the company withdrew its forecast entirely, saying that medical costs from new Medicare Advantage members were higher than expected. UnitedHealth's stock jumped more than 12% in premarket trading on Friday. Still, the stock has lost roughly half its value in the past year. Chapman writes for the Associated Press.
CNBC
9 hours ago
- CNBC
Ivy League-trained psychologist: These 3 'very powerful' steps will build your emotional endurance
Being recognized as a resilient person feels great. Weathering the tough moments that build resilience is less glamorous. Developing emotional endurance, or the ability to withstand stress or discomfort without letting negative emotions overtake you, can help that process feel less grueling and more like an opportunity to learn and grow, Columbia University-trained psychologist Becky Kennedy tells CNBC Make It. "The more we understand that the frustration and struggle is actually a sign we're [learning], not a sign we're doing something wrong, it becomes a lot easier to tolerate," says Kennedy, a New York-based clinical psychologist and host of the "Good Inside" podcast. You can get to this state of understanding by following these three steps, she says: In a February Instagram Reel, Kennedy explained that learning happens between the space of knowing and not knowing something. You don't always instantly gain knowledge where you previously had none, and the process of getting from Point A to Point B can feel frustrating, says Kennedy. When you start a new job, for example, you'll likely have to learn some new skills, make some mistakes and foster some new connections before you start to feel comfortable in the role. The path between knowing and not knowing something is much more like a winding line than a straight and narrow one, Kennedy says — so when you feel frustrated, remind yourself that learning takes time. You can do this by drawing or looking at a simple diagram of the scenario, like this one: "Having some type of visual for yourself is very, very helpful," says Kennedy. "Every time you're trying to do something new, when your voice starts to say, 'Oh, this is too hard. I can't figure it out,' the visual gives you a different story. 'I'm in the learning space. I'm kind of exactly where I'm supposed to be. It just happens to be tricky.'" If you constantly tell yourself "this is too hard" or "I'm never going to get there," you start to believe it. Shift your internal dialogue to something more positive, supportive and understanding, advises Kennedy. Try telling yourself something like this, she says: "This feels hard because it is hard. I haven't figured it out yet, and I can keep trying. I can take a breath and take a break and come back when I'm ready." Even if you don't believe what you're telling yourself, going through the motions — essentially, faking it until you make it — will help, because the practice will help you feel more confident over time, she says. "Self-talk is very powerful. How we end up feeling about something is a combination of the feeling and how we talk to ourselves about the feeling, and we can't change our feelings, but we can change how we talk to ourselves about our feelings," says Kennedy. Positive self-talk can improve your coping skills and build your mental strength, allowing you to put in more effort than you think you're capable of, according to a 2020 study published in the Journal of Sports Science and Management. It can increase your internal motivation and even help you enjoy learning more, the study found. Start with small goals instead of expecting yourself to quickly reach your long-term vision, says Kennedy. If you set a huge goal and fall short of it, you're unlikely to try again anytime soon, she says. If you want to be more active, commit to taking a 20 minute walk three times per week instead of trying to hit the gym for an hour every day, for example. "Take on a small experiment that feels uncomfortable for you: I am going to talk to my boss about those things that's upsetting. I am going to have that conversation with my friend," Kennedy says. "Those are small experiments that tell your body, 'I am someone who can be in the learning space and tolerate discomfort.' The more our body learns that we can tolerate that space, the more we're able to tolerate it in other areas as well."
